Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007493417> ?p ?o ?g. }
- W3007493417 endingPage "167.e9" @default.
- W3007493417 startingPage "167.e1" @default.
- W3007493417 abstract "GRN mutations are frequent causes of familial frontotemporal degeneration. Although there is no clear consensual threshold, plasma progranulin levels represent an efficient biomarker for predicting GRN mutations when decreased. We evaluated plasma levels to determine whether it could also predict age at onset, clinical phenotype, or disease progression in 160 GRN carriers. Importantly, progranulin levels were influenced by gender, with lower levels in male than in female patients in our study. Although we found no correlation with age at onset or with clinical phenotype, we confirmed that decreased level predicts GRN mutations, even in presymptomatic carriers more than four decades before disease onset. We also provided first evidence for the stability of levels throughout longitudinal trajectory in carriers, over a 4-year time span. Finally, we confirmed that progranulin levels constitute a reliable, cost-effective marker, suitable as a screening tool in patients with familial frontotemporal degeneration, and more broadly in patients without family history or with atypical presentations who are less likely to be referred for molecular diagnosis." @default.
- W3007493417 created "2020-03-06" @default.
- W3007493417 creator A5008499402 @default.
- W3007493417 creator A5016849500 @default.
- W3007493417 creator A5017805570 @default.
- W3007493417 creator A5023778362 @default.
- W3007493417 creator A5023790896 @default.
- W3007493417 creator A5024848742 @default.
- W3007493417 creator A5025435438 @default.
- W3007493417 creator A5027489586 @default.
- W3007493417 creator A5032426975 @default.
- W3007493417 creator A5042566383 @default.
- W3007493417 creator A5047832471 @default.
- W3007493417 creator A5053457443 @default.
- W3007493417 creator A5054223352 @default.
- W3007493417 creator A5055524428 @default.
- W3007493417 creator A5057016612 @default.
- W3007493417 creator A5060787402 @default.
- W3007493417 creator A5063244635 @default.
- W3007493417 creator A5063744167 @default.
- W3007493417 creator A5064360632 @default.
- W3007493417 creator A5067733275 @default.
- W3007493417 creator A5068609987 @default.
- W3007493417 creator A5075804608 @default.
- W3007493417 creator A5076157373 @default.
- W3007493417 creator A5077897163 @default.
- W3007493417 creator A5078304440 @default.
- W3007493417 creator A5079793569 @default.
- W3007493417 creator A5081190381 @default.
- W3007493417 creator A5083101187 @default.
- W3007493417 creator A5084179815 @default.
- W3007493417 creator A5091618250 @default.
- W3007493417 date "2020-07-01" @default.
- W3007493417 modified "2023-10-18" @default.
- W3007493417 title "Plasma progranulin levels for frontotemporal dementia in clinical practice: a 10-year French experience" @default.
- W3007493417 cites W1669316029 @default.
- W3007493417 cites W1967144275 @default.
- W3007493417 cites W1993239839 @default.
- W3007493417 cites W1994089264 @default.
- W3007493417 cites W2001811842 @default.
- W3007493417 cites W2005731595 @default.
- W3007493417 cites W2013832594 @default.
- W3007493417 cites W2024275519 @default.
- W3007493417 cites W2027460468 @default.
- W3007493417 cites W2028243202 @default.
- W3007493417 cites W2032142579 @default.
- W3007493417 cites W2045921574 @default.
- W3007493417 cites W2077311804 @default.
- W3007493417 cites W2098219309 @default.
- W3007493417 cites W2101738226 @default.
- W3007493417 cites W2106786486 @default.
- W3007493417 cites W2125044837 @default.
- W3007493417 cites W2128030851 @default.
- W3007493417 cites W2138190873 @default.
- W3007493417 cites W2146535845 @default.
- W3007493417 cites W2152481146 @default.
- W3007493417 cites W2163955717 @default.
- W3007493417 cites W2165005499 @default.
- W3007493417 cites W2262171011 @default.
- W3007493417 cites W2429544251 @default.
- W3007493417 cites W2487820682 @default.
- W3007493417 cites W2499035107 @default.
- W3007493417 cites W2770087407 @default.
- W3007493417 cites W2807756255 @default.
- W3007493417 cites W2885696102 @default.
- W3007493417 cites W2993046104 @default.
- W3007493417 cites W4256606937 @default.
- W3007493417 doi "https://doi.org/10.1016/j.neurobiolaging.2020.02.014" @default.
- W3007493417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32171590" @default.
- W3007493417 hasPublicationYear "2020" @default.
- W3007493417 type Work @default.
- W3007493417 sameAs 3007493417 @default.
- W3007493417 citedByCount "19" @default.
- W3007493417 countsByYear W30074934172020 @default.
- W3007493417 countsByYear W30074934172021 @default.
- W3007493417 countsByYear W30074934172022 @default.
- W3007493417 countsByYear W30074934172023 @default.
- W3007493417 crossrefType "journal-article" @default.
- W3007493417 hasAuthorship W3007493417A5008499402 @default.
- W3007493417 hasAuthorship W3007493417A5016849500 @default.
- W3007493417 hasAuthorship W3007493417A5017805570 @default.
- W3007493417 hasAuthorship W3007493417A5023778362 @default.
- W3007493417 hasAuthorship W3007493417A5023790896 @default.
- W3007493417 hasAuthorship W3007493417A5024848742 @default.
- W3007493417 hasAuthorship W3007493417A5025435438 @default.
- W3007493417 hasAuthorship W3007493417A5027489586 @default.
- W3007493417 hasAuthorship W3007493417A5032426975 @default.
- W3007493417 hasAuthorship W3007493417A5042566383 @default.
- W3007493417 hasAuthorship W3007493417A5047832471 @default.
- W3007493417 hasAuthorship W3007493417A5053457443 @default.
- W3007493417 hasAuthorship W3007493417A5054223352 @default.
- W3007493417 hasAuthorship W3007493417A5055524428 @default.
- W3007493417 hasAuthorship W3007493417A5057016612 @default.
- W3007493417 hasAuthorship W3007493417A5060787402 @default.
- W3007493417 hasAuthorship W3007493417A5063244635 @default.
- W3007493417 hasAuthorship W3007493417A5063744167 @default.
- W3007493417 hasAuthorship W3007493417A5064360632 @default.
- W3007493417 hasAuthorship W3007493417A5067733275 @default.